Patents by Inventor Tanya Warnecke Lipscomb

Tanya Warnecke Lipscomb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10494654
    Abstract: A microbial cell is used for producing at least one fatty acid ester, wherein the cell is genetically modified to contain (i) at least one first genetic mutation that enables the cell to produce at least one fatty acid and/or acyl coenzyme A (CoA) thereof by increased enzymatic activity in the cell relative to the wild type cell of malonyl-CoA dependent and malonyl-ACP independent fatty acyl-CoA metabolic pathway, wherein the fatty acid contains at least 5 carbon atoms; and (ii) a second genetic mutation that increases the activity of at least one wax ester synthase in the cell relative to the wild type cell and the wax ester synthase has sequence identity of at least 50% to a polypeptide of SEQ ID NO: 1-8 and combinations thereof or to a functional fragment of any of the polypeptides for catalyzing the conversion of fatty acid and/or acyl coenzyme A thereof to the fatty acid ester.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: December 3, 2019
    Assignee: CARGILL, INCORPORATED
    Inventors: Katrin Grammann, Jan Wolter, Liv Reinecke, Steffen Schaffer, Eileen E. Spindler, Wendy K. Ribble, Brittany L. Robinson, Catherine B. Poor, Tanya Warnecke Lipscomb, Hans H. Liao, David A. Hogsett, Ronald J. Evans
  • Publication number: 20180312886
    Abstract: Metabolically engineered microorganism strains are disclosed, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product. Such chemical products include polyketides, 3-hydroxypropionic acid, and various other chemical products described herein. Methods of production also may be applied to further downstream products, such as consumer products. In various embodiments, modifications to a microorganism and/or culture system divert, at least transiently, usage of malonyl-coA from the fatty acid biosynthesis pathway and thereby provides for usage of the malonyl-coA for a chemical product other than a fatty acid. In various embodiments, the fatty acid biosynthesis pathway is modulated to produce specific fatty acids or combinations of fatty acids.
    Type: Application
    Filed: July 9, 2018
    Publication date: November 1, 2018
    Inventors: Michael D. Lynch, Tanya Warnecke Lipscomb, Ashley D. Trahan, Amarjeet Singh, Travis Wolter
  • Publication number: 20180312887
    Abstract: Metabolically engineered microorganism strains are disclosed, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product. Such chemical products include polyketides, 3-hydroxypropionic acid, and various other chemical products described herein. Methods of production also may be applied to further downstream products, such as consumer products. In various embodiments, modifications to a microorganism and/or culture system divert, at least transiently, usage of malonyl-coA from the fatty acid biosynthesis pathway and thereby provides for usage of the malonyl-coA for a chemical product other than a fatty acid. In various embodiments, the fatty acid biosynthesis pathway is modulated to produce specific fatty acids or combinations of fatty acids.
    Type: Application
    Filed: July 9, 2018
    Publication date: November 1, 2018
    Inventors: Michael D. Lynch, Tanya Warnecke Lipscomb, Ashley D. Trahan, Amarjeet Singh, Travis Wolter
  • Publication number: 20180273990
    Abstract: A microbial cell is used for producing at least one fatty acid ester, wherein the cell is genetically modified to contain (i) at least one first genetic mutation that enables the cell to produce at least one fatty acid and/or acyl coenzyme A (CoA) thereof by increased enzymatic activity in the cell relative to the wild type cell of malonyl-CoA dependent and malonyl-ACP independent fatty acyl-CoA metabolic pathway, wherein the fatty acid contains at least 5 carbon atoms; and (ii) a second genetic mutation that increases the activity of at least one wax ester synthase in the cell relative to the wild type cell and the wax ester synthase has sequence identity of at least 50% to a polypeptide of SEQ ID NO: 1-8 and combinations thereof or to a functional fragment of any of the polypeptides for catalyzing the conversion of fatty acid and/or acyl coenzyme A thereof to the fatty acid ester.
    Type: Application
    Filed: March 12, 2018
    Publication date: September 27, 2018
    Inventors: Katrin GRAMMANN, Jan WOLTER, Liv REINECKE, Steffen SCHAFFER, Eileen E. SPINDLER, Wendy K. RIBBLE, Brittany L. PRATHER, Catherine B. POOR, Tanya Warnecke LIPSCOMB, Hans H. LIAO, Dave A. HOGSETT, Ronald J. EVANS
  • Patent number: 9944959
    Abstract: A microbial cell is used for producing at least one fatty acid ester, wherein the cell is genetically modified to contain (i) at least one first genetic mutation that enables the cell to produce at least one fatty acid and/or acyl coenzyme A (CoA) thereof by increased enzymatic activity in the cell relative to the wild type cell of malonyl-CoA dependent and malonyl-ACP independent fatty acyl-CoA metabolic pathway, wherein the fatty acid contains at least 5 carbon atoms; and (ii) a second genetic mutation that increases the activity of at least one wax ester synthase in the cell relative to the wild type cell and the wax ester synthase has sequence identity of at least 50% to a polypeptide of SEQ ID NO: 1-8 and combinations thereof or to a functional fragment of any of the polypeptides for catalyzing the conversion of fatty acid and/or acyl coenzyme A thereof to the fatty acid ester.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: April 17, 2018
    Assignee: CARGILL, INCORPORATED
    Inventors: Katrin Grammann, Jan Wolter, Liv Reinecke, Steffen Schaffer, Eileen C. Spindler, Wendy K. Ribble, Brittany L. Prather, Catherine B. Poor, Tanya Warnecke Lipscomb, Hans H. Liao, Dave A. Hogsett, Ronald J. Evans
  • Publication number: 20160060663
    Abstract: A microbial cell is used for producing at least one fatty acid ester, wherein the cell is genetically modified to contain (i) at least one first genetic mutation that enables the cell to produce at least one fatty acid and/or acyl coenzyme A (CoA) thereof by increased enzymatic activity in the cell relative to the wild type cell of malonyl-CoA dependent and malonyl-ACP independent fatty acyl-CoA metabolic pathway, wherein the fatty acid contains at least 5 carbon atoms; and (ii) a second genetic mutation that increases the activity of at least one wax ester synthase in the cell relative to the wild type cell and the wax ester synthase has sequence identity of at least 50% to a polypeptide of SEQ ID NO: 1-8 and combinations thereof or to a functional fragment of any of the polypeptides for catalyzing the conversion of fatty acid and/or acyl coenzyme A thereof to the fatty acid ester.
    Type: Application
    Filed: September 2, 2015
    Publication date: March 3, 2016
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Katrin GRAMMANN, Jan Wolter, Liv Reinecke, Steffen Schaffer, Eileen C. Spindler, Wendy K. Ribble, Brittany L. Prather, Catherine B. Poor, Tanya Warnecke Lipscomb, Hans H. Liao, Dave A. Hogsett, Ronald J. Evans